Skip to main content
SpringerLink
Log in

5-HT1A receptor agonists: recent developments and controversial issues

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

During the last decade, serotonin (5-HT)1A receptors have been a major target for neurobiological research and drug development. 5-HT1A receptors have been cloned and a variety of selective agonists, such as the aminotetraline 8-OH-DPAT and the pyrimidinylpiperazine ipsapirone, have become available. Demonstrations of apparent intrinsic activity of these ligands at 5-HT1A receptors, however, depend highly on the particular assay system. This may be due to the possible existence of receptor subtypes and to assay (or brain region)-dependent differences in receptor reserve and the nature of receptor-effector coupling. Nevertheless, the apparent intrinsic activity of 8-OH-DPAT seems to be higher (although possibly not yet maximal) than that of the pyrimidinylpiperazines. In the brain, 5-HT1A receptors are located presynaptically as somatodendritic receptors on 5-HT neurons and postsynaptically in particular limbic and cortical regions. Although it is generally accepted that presynaptic 5-HT1A receptors control 5-HT neuronal activity, recent evidence suggests an additional role of postsynaptic 5-HT1A receptors in cortex as part of a negative feedback loop. Anxiolytic and antidepressive properties of selective 5-HT1A receptor agonists have now been confirmed by clinical studies. Although it is well established that the latter properties depend on theagonistic activity of these compounds, theoptimal level of intrinsic activity is still a matter of debate and may be dependent on the clinical indication. Such compounds may also have antiaggressive effects, and possibly anticraving effects (manifested by their alcohol intake-reducing effects in dependent animals), but the specificity of these so-called anti-impulsivity effects is still controversial and not yet tested clinically. Anticataleptic, antiemetic and neuroprotective properties have been demonstrated in different species. Behavioral studies on the mechanisms underlying the anxiolytic and antidepressive effects have examined the relative contribution of pre-and postsynaptic 5-HT1A receptors by means of local cerebral application and lesion techniques. Most evidence points towards a critical involvement of presynaptic receptors in the anxiolytic effects of 5-HT1A receptor agonists (although a possible contribution of postsynaptic receptors cannot be excluded). With regard to the antidepressive properties, a case can be made for the reverse; i.e., a strong involvement of postsynaptic receptors and a questionable contribution of presynaptic receptors. However, as the therapeutic effects of those 5-HT1A receptor (partial) agonists which have been tested clinically require repeated administration, attention has been directed increasingly towards chronic studies. These studies have shown that a number of electrophysiological, biochemical, behavioral and endocrinological 5-HT1A receptor-related events adapt differentially to repeated or sustained administration. Thus, several hypotheses accounting for the delayed onset of action have been advanced. Among these, time-dependent downregulation /desensitization of eitherpre- orpostsynaptic 5-HT1A receptors, or cortical 5-HT2 receptors have received much attention. However, these hypotheses have their weaknesses, and it is argued thatfunctional sensitization of particular postsynaptic 5-HT1A receptor-mediated events remains a valuable alternate hypothesis. Basic research on the role of 5-HT1A receptors in psychopathology and in the therapeutic effects of clinically effective therapeutics, as well as on the mechanism of action of 5-HT1A receptor ligands, will enable rational design of ligands with particular profiles of intrinsic activity at different 5-HT1A receptor populations, and may contribute to a more efficient treatment of a multiplicity of brain disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andrade R (1992) Electrophysiology of 5-HT1A receptors in the rat hippocampus and cortex. Drug Dev Res 26:275–286

    Google Scholar 

  • Andrews N, Hogg S, Gonzales LE, File SE (1994) 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol 264:259–264

    Google Scholar 

  • Araneda R, Andrade R (1991) 5-HT2 and 5-HT1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40:399–412

    Google Scholar 

  • Barrett JE, Vanover K (1993) 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology 112:1–12

    Google Scholar 

  • Basse-Tomusk A, Rebec GV (1986) Ipsapirone depresses neuronal activity in the dorsl raphe nucleus and the hippocampal formation. Eur J Pharmacol 130:141–143

    Google Scholar 

  • Baudrie V, Chaouloff F (1991) Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat. Eur J Pharmacol 198:129–135

    Google Scholar 

  • Baudrie V, De Vry J, Broqua P, Schmidt B, Chaouloff F, Glaser T (1992) Subchronic treatment with anxiolytic doses of the 5-HT1A agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat. Eur J Pharmacol 231:395–406

    Google Scholar 

  • Beck SG, Choi KC, List TJ (1992) Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 263:350–359

    Google Scholar 

  • Beer M, Kennett GA, Curzon G (1990) A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur J Pharmacol 178:179–187

    Google Scholar 

  • Bell R, Hobson H (1994) 5-HT1A receptor influences on rodent social and agonistic behavior: a review and empirical study. Neurosci Biobehav Rev 18:325–338

    Google Scholar 

  • Benjamin D, Saiff EJ, Lal H, Coupet J (1990) Down regulation of brain 5-HT2 receptors underlies anxiolytic effect produced by sustained treatment with gepirone. Soc Neurosci Abstr 16:1323

    Google Scholar 

  • Bielenberg GW, Burkhardt M (1990) 5-HT1A agonists show neuroprotectant activity in rats and mice. Eur J Pharmacol 183:1953–1954

    Google Scholar 

  • Blier P, de Montigny (1987) Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1:470–480

    Google Scholar 

  • Blier P, Lista A, de Montigny C (1993a) Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. J Pharmacol Exp Ther 265:7–15

    Google Scholar 

  • Blier P, Lista A, de Montigny C (1993b) Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins. J Pharmacol Exp Ther 265:16–23

    Google Scholar 

  • Blier P, Seletti B, Bouchard C, Artigas F, de Montigny C (1994) Functional evidence for the differential responsiveness of pre- and postsynaptic 5-HT1A receptors in rat brain. Soc Neurosci Abstr 20:1540

    Google Scholar 

  • Boddeke HWGM, Fargin A, Raymond JR, Schoeffter P, Hoyer D (1992) Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells. Naunyn-Schmiedeberg's Arch Pharmacol 345:257–263

    Google Scholar 

  • Bode-Greuel KM, Klisch J, Glaser T, Traber J (1990) Serotonin(5-HT)1A receptor agonists as neuroprotective agents in cerebral ischemia. In: Krieglstein J, Oberpichler H (eds) Pharmacology of cerebral ischemia. Wißenschaftliche Verlagsgesellschaft, Stuttgart, pp 485–491

    Google Scholar 

  • Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ (1989) A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology 97:277–279

    Google Scholar 

  • Bohmaker K, Eison AS, Yocca FD, Meller E (1993) Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors. Neuropharmacology 32:527–534

    Google Scholar 

  • Broekkamp CLE, Oosterloo SK, Berendsen HHG, van Delft AML (1988) Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine. Psychopharmacology 338:191–195

    Google Scholar 

  • Carli M, Samanin R (1988) Potential anxiolytic properties of 8-hydroxy-2-(di-N-propylamino)tetralin, a selective serotonin1A receptor agonist. Psychopharmacology 94:84–91

    Google Scholar 

  • Carli M, Tatarczynska E, Cervo L, Samanin R (1993) Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not anti-depressant-like effects in the rat. Eur J Pharmacol 234:215–221

    Google Scholar 

  • Ceci A, Baschirotto A, Borsini F (1992) Effects of 5-HT monoamine uptake blockers and 5-HT1A agonists on spontaneous firing rate of prefrontal cortical neurons. Soc Neurosci Abstr 18:749

    Google Scholar 

  • Ceci A, Baschirotto A, Borsini F (1994) The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology 33:709–713

    Google Scholar 

  • Cervo L, Samanin R (1987) Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. Eur J Pharmacol 144:223–229

    Google Scholar 

  • Cervo L, Samanin R (1991) Effect of chronic treatment with 8-OH-DPAT in the forced swimming test requires the integrity of presynaptic serotonergic mechanisms. Psychopharmacology 103:524–528

    Google Scholar 

  • Cervo L, Grignaschi G, Samanin R (1988a) 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur J Pharmacol 158:53–59

    Google Scholar 

  • Cervo L, Grignaschi G, Samanin R (1988b) Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of a metabolite. Life Sci 43:2095–2102

    Google Scholar 

  • Chen C-C, Fujiwara Y, Akiyama K, Ujike H, Moriya F, Otsuki S (1992) Voluntary intake of alcohol is attenuated by ipsapirone in mice and role of 5-HT1A receptor. Jpn J Psychiatr Neurol 46:197–203

    Google Scholar 

  • Cobain MR, Forster EA, Mitchell PJ, Fletcher A (1994) The antidepressant effect of 5-HT1A ligands is mediated by agonist activity at 5-HT1A receptors. J Psychopharmacol A7

  • Colino A, Halliwell JV (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature 328:73–77

    Google Scholar 

  • Costello NL, Carlson JN, Glick SD, Bryda M (1991) The effects of acute administration of gepirone in rats trained on conflict schedules having different degrees of predictability. Pharmacol Biochem Behav 40:795–800

    Google Scholar 

  • De Souza RJ, Goodwin GM, Green AR, Heal DJ (1986) Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists. Br J Pharmacol 89:377–384

    Google Scholar 

  • De Vry J, Schreiber R (1993) Comparison of acute and repeated treatment with the 5-HT1A receptor ligands 8-OH-DPAT and ipsapirone in animal models of anxiety and depression. Drug Dev Res 30:91–103

    Google Scholar 

  • De Vry J, Schreiber R, Glaser T (1991a) Behavioral pharamcology of the 5-HT1A receptor ligands ipsapirone and 8-OH-DPAT in rats after repeated administration. Soc Neurosci Abstr 17:281

    Google Scholar 

  • De Vry J, Glaser T, Schuurman T, Schreiber R, Traber J (1991b) 5-HT1A receptors in anxiety. In: Briley M, File SE (eds) New concepts in anxiety. MacMillan Press, London, pp 94–129

    Google Scholar 

  • De Vry J, Schreiber R, Glaser T, Traber J (1992) Behavioral pharmacology of 5-HT1A agonists: animal models of anxiety and depression. In: Stahl SM, Gastpar M, Keppel Hesselink JM, Traber J (eds) Serotonin1A receptors in depression and anxiety. Raven Press, New York, pp 55–81

    Google Scholar 

  • De Vry J, Benz U, Schreiber R, Traber T (1993) Shock-induced ultrasonic vocalization in young adult rats: an animal model for testing anxiolytic activity of putative anti-anxiety drugs. Eur J Pharmacol 249:331–339

    Google Scholar 

  • De Vry J, Lohmann A, Schneider R, de Beun R (1994a) Studies on the behavioral mechanisms underlying the alcohol intake-reducing effect of the 5-HT1A receptor agonist ipsapirone. Behav Pharmacol 5:98

    Google Scholar 

  • De Vry J, Sommermeyer H, Horvath E, Glaser T (1994b) Attenuation of haloperidol-induced dopamine release as a possible biochemical correlate for the anticataleptic effects of the 5-HT1A receptor agonist 8-OH-DPAT. Neuropharmacology 10:194S

    Google Scholar 

  • Done CJG, Sharp T (1994) Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology 33:411–421

    Google Scholar 

  • Dourish CT (1987) Brain 5-HT1A receptors and anxiety. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors. Ellis Horwood, Chichester, pp 261–277

    Google Scholar 

  • Dumuis S, Sebben M, Bockaert J (1988) Pharmacology of 5-hydroxytryptamine 1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Mol Pharmacol 33:178–186

    Google Scholar 

  • Eison AS, Yocca FD (1985) Reduction in cortical 5HT2 receptor sensitivity after continuous gepirone treatment. Eur J Pharmacol 111:389–392

    Google Scholar 

  • Evenden JL, Lundgren K (1990) Tolerance to the hypothermic effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat. Psychopharmacology 101:S18

    Google Scholar 

  • Fanelli R, McMonagle-Strucko (1992) Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography. Synapse 12:75–81

    Google Scholar 

  • Fletcher A, Cliffe IA, Dourish CT (1993) Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol Sci 14:441–448

    Google Scholar 

  • Forster EA, Cronin SM, Sanford J, Fletcher A (1994a) Desensitisation of postsynaptic 5-HT1A receptors following single administration of 5-HT1A ligands. Br J Pharmacol 111:146P

  • Forster EA, Marsden CA, Mitchell PJ, Fletcher A (1994b) In vivo adaptational responses to the repeated administration of selective 5-HT1A receptor ligands. Br J Pharmacol 112:647P

  • Gatto GJ, McBride WJ, Murphy JM, Lumeng L, Li T-K (1987) Effects of serotonin (5-HT) agonists on alcohol drinking behavior of the NP (alcohol-nonpreferring) line of rats. Alcohol Clin Exp Res 11:195

    Google Scholar 

  • Glaser T, De Vry J (1992) Neurobiology of 5-HT1A receptors. In: Stahl SM, Gastpar M, Keppel Hesselink JM, Traber J (eds) Serotonin1A receptors in depression and anxiety. Raven Press, New York, pp 35–53

    Google Scholar 

  • Glaser T, Greuel JM, Horvath E, Schreiber R, De Vry J (1991) Differentiation of 8-OH-DPAT and ipsapirone in rat models of 5-HT1A receptor function. In: Fozard JR, Saxena PR (eds) Serotonin: molecular biology, receptors and functional effects. Birkhauser, Basel, pp 460–470

    Google Scholar 

  • Godbout R, Chaput Y, Blier P, de Montigny C (1991) Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine: I. Effects of acute and long-term tandospirone on serotonin neurotransmission. Neuropharmacology 30:679–690

    Google Scholar 

  • Golembiowska K (1992) Effect of acute and chronic treatment of rats with the putative anxiolytic drug ipsapirone on the turnover of monoamine transmitters in various brain regions: a comparison with the 5-HT1A agonist 8-hydroxy-DPAT. Pol J Pharmacol Pharm 44:15–24

    Google Scholar 

  • Goodwin GM, De Souza RJ, Green AR (1986) The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats. Psychopharmacology 89:382–387

    Google Scholar 

  • Goudie AJ, Leathly MJ (1990) Tolerance to the 5-HT1A agonist ipsapirone: differences between assays. J Psychopharmacol 4:292

    Google Scholar 

  • Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H (1988) Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. J Pharmacol Exp Ther 246:745–752

    Google Scholar 

  • Hamon M, Lanfumey L, Haj-Dahmane S, Jolas T, Kidd E, Bolaños F, Gozlan H (1991) Adaptation of central 5-HT1A receptors after chronic antidepressant treatment in rats. In: Racagni G, Brunello N, Fukada T (eds) Biological psychiatry, vol 1. Elsevier, Amsterdam, pp 297–300

    Google Scholar 

  • Handley SL, McBlane JW (1993) 5HT drugs in animal models of anxiety. Psychopharmacology 112:13–20

    Google Scholar 

  • Higgins GA, Bradbury AJ, Jones BJ, Oakley NR (1988) Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat. Neuropharmacology 27:993–1001

    Google Scholar 

  • Higgins GA, Jones BJ, Oakley NR (1992a) Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection. Psychopharmacology 106:261–267

    Google Scholar 

  • Higgins GA, Tomkins DM, Fletcher PJ, Sellers EM (1992b) Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: studies using a drinkometer system. Neurosci Biobehav Rev 16:535–552

    Google Scholar 

  • Hodges H, Green S, Glenn B (1987) Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not discrimination. Psychopharmacology 92:491–504

    Google Scholar 

  • Hogg S, Andrews N, File SE (1994) Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology 33:343–348

    Google Scholar 

  • Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157–203

    Google Scholar 

  • Jankowska E, Bidzinski A, Kostowski W (1994) Alcohol drinking in rats treated with 5,7-dihydroxytryptamine: effect of 8-OH-DPAT and tropisetron (ICS 205-930) Alcohol 11:283–288

    Google Scholar 

  • Johansson CE, Meyerson BJ (1991) The effects of long-term treatment with 8-OH-DPAT on lordosis response and hypothermia in female rats. Eur J Pharmacol 196:143–147

    Google Scholar 

  • Johansson CE, Meyerson BJ, Höglund AU (1990) The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats. Eur J Pharmacol 178:1–9

    Google Scholar 

  • Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, Gozlan H, Guardiola-Lemaitre B, Hamon M (1993) (−) Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 347:453–463

    Google Scholar 

  • Jolas T, Schreiber R, Laporte AM, Gaymard C, De Vry J, Glaser T, Adrien J, Hamon M (1995) Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat dorsal raphe nucleus? J Pharmacol Exp Ther 272:920–929

    Google Scholar 

  • Kataoka Y, Shibata K, Miyazaki A, Inoue Y, Tominaga K, Koizumi S, Ueki S, Niwa M (1991) Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic. Neuropharmacology 30:475–480

    Google Scholar 

  • Kelder D, Ross SB (1992) Long lasting attenuation of 8-OH-DPAT-induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist. Naunyn-Schmiedeberg's Arch Pharmacol 346:121–126

    Google Scholar 

  • Kennett GA, Marcou M, Dourish CT, Curzon G (1987) Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol 138:53–60

    Google Scholar 

  • Klancnik JM, Baimbridge, Phillips AG (1989) Increased population spike amplitude in the dendate gyrus following systemic administration of 5-hydroxytryptophan or 8-hydroxy-2-(di-n-propylamino) tetralin. Brain Res 505:145–148

    Google Scholar 

  • Knapp DJ, Benjamin D, Pohorecky LA (1992) Effects of gepirone on ethanol consumption, exploratory behavior, and motor performance in rats. Drug Dev Res 26:319–341

    Google Scholar 

  • Kolbasa KP, McCall RB, Ludens JH (1991) Effect of chronic treatment on cardiovascular and behavioral responses of 8-OH-DPAT in conscious normotensive rats. Eur J Pharmacol 193:275–281

    Google Scholar 

  • Kostowski W, Dyr W (1992) Effects of 5-HT1A receptor agonists on ethanol preference in the rat. Alcohol 9:283–286

    Google Scholar 

  • Kreiss DS, Lucki I (1992) Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT. Neuropharmacology 31:1073–1076

    Google Scholar 

  • Larsson L-G, Rényi L, Ross SB, Svensson B, Ängeby-Möller K (1990) Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT. Neuropharmacology 29:85–91

    Google Scholar 

  • Leishman DJ, Boeijinga PH, Galvan M (1994) Differential effects of centrally-active antihypertensives on 5-HT1A receptors in rat dorso-lateral septum, rat hippocampus and guinea-pig hippocampus. Br J Pharmacol 111:318–324

    Google Scholar 

  • Lucki I, Kreiss DS (1992) Chronic administration of the 5-HT1A agonist 8-OH-DPAT produces desensitization of 5-HT1A autoreceptors. Soc Neurosci Abstr 18:1382

    Google Scholar 

  • Lucki I, Singh A, Kreiss DS (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 18:85–95

    Google Scholar 

  • Lucot JB, Crampton GH (1989) 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine. Pharmacol Biochem Behav 33:627–631

    Google Scholar 

  • Luscombe GP, Martin KF, Hutchins LJ, Gosden J, Heal DJ (1993) Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors. Br J Pharmacol 108:669–677

    Google Scholar 

  • Manhan-Vaughan D, Anwyl R, Rowan MJ (1994a) 5-HT1A receptor-mediated inhibition in the hippocampus of the alert rat — effects of repeated gepirone treatment. Eur J Pharmacol 260:149–155

    Google Scholar 

  • Manhan-Vaughan D, Anwyl R, Rowan MJ (1994b) Adaptive changes in 5-HT1A receptor-mediated hippocampal inhibition in the alert rat produced by repeated 8-OH-DPAT treatment. Br J Pharmacol 112:1083–1088

    Google Scholar 

  • Martin KF, Mason R (1987) Ipsapirone is a partial agonist at 5-hydroxytryptamine1A (5-HT1A) receptors in the rat hippocampus: electrophysiological evidence. Eur J Pharmacol 141:479–483

    Google Scholar 

  • Martin KF, Phillips I, Hearson M, Prow MR, Heal DJ (1992) Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br J Pharmacol 107:15–21

    Google Scholar 

  • Martin P, Tissier M-H, Adrien J, Puech AJ (1991) Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm. Life Sci 48:2505–2511

    Google Scholar 

  • McBride WJ, Murphy JM, Lumeng L, Li T-K (1990) Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats. Alcohol 7:199–205

    Google Scholar 

  • McCormick DA, Williamson A (1989) Convergence of neurotransmitter action in human cerebral cortex. Proc Natl Acad Sci USA 86:8098–8102

    Google Scholar 

  • McMillen BA, Williams HL (1990) Effects of chronic ipsapirone on rat brain monoaminergic receptors and responses to chronic antipsychotic treatment. Biogenic Amines 7:569–575

    Google Scholar 

  • McMillen BA, Scott SM, Davanzo EA (1988) Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs. J Pharm Pharmacol 40:885–887

    Google Scholar 

  • McMillen BA, Wooten MH, King SW, Williams HL (1992) Interactions between subchronic administration of alprazolam and aryl-piperazine anxiolytic drugs in aggressive mice. Biogenic Amines 9:131–140

    Google Scholar 

  • Meller E, Chalfin M, Bohmaker K (1992) Serotonin 5-HT1A receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance. Pharmacol Biochem Behav 43:405–411

    Google Scholar 

  • Meijer OC, de Kloet ER (1994) Corticosterone suppresses the expression of 5-HT1A receptor mRNA in the rat dendate gyrus. Eur J Pharmacol [Mol Pharmacol Sect] 266:255–261

    Google Scholar 

  • Meller E, Goldstein M, Bohmaker K (1990) Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol Pharmacol 37:231–237

    Google Scholar 

  • Miczek KA, Weerts EM, Vivian JA, Barros HM (1995) Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics. Psychopharmacology (in press)

  • Motta V, Maisonnette S, Morato S, Castrechini P, Brandao ML (1992) Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze. Psychopharmacology 107:135–139

    Google Scholar 

  • Murphy JM, McBride WJ, Lumeng L, Li T-K (1987) Effects of serotonergic agents on ethanol intake of the high alcohol drinking (HAD) line of rats. Alcohol Clin Exp Res 11:208

    Google Scholar 

  • Murthy JN, Pranzatelli (1991) Regulation of brainstem 5-HT1A receptors in the rat. Soc Neurosci Abstr 17:275

    Google Scholar 

  • Nader MA, Barrett JE (1989) Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) Pharmacol Biochem Behav 32:227–232

    Google Scholar 

  • Nakano Y, Matsuda T, Takuma K, Yoshikawa T, Baba A (1992) Sex difference for tolerance of 5-HT1A receptor-mediated temperature and corticosterone responses in mice. Eur J Pharmacol 219:339–341

    Google Scholar 

  • Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA (1994) Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin. J Neurochem 62:1822–1834

    Google Scholar 

  • Newberry NR (1992) 5-HT1A receptors activate a potassium conductance in rat ventromedial hypothalamic neurones. Eur J Pharmacol 210:209–212

    Google Scholar 

  • Newman ME, Shapira B, Lerer B (1992) Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short-and long-term administration of 5-hydroxytryptamine1A agonists and antidepressants. J Pharmacol Exp Ther 260:16–20

    Google Scholar 

  • O'Connor JJ, Rowan MJ, Anwyl R (1990) Actions of 5-HT1 ligands on excitatory synaptic transmission in the hippocampus of alert rats. Br J Pharmacol 101:171–177

    Google Scholar 

  • Penington NJ, Kelly JS, Fox AP (1991) A study of the mechanism of Ca2+ current inhibition produced by serotonin in rat dorsal raphe neurons. J Neurosci 11:3594–3609

    Google Scholar 

  • Peroutka SJ (1994) Molecular biology of serotonin (5-HT) receptors. Synapse 18:241–260

    Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Long term antidepressant treatment lowering spiperidol labelled serotonin receptor binding. Science 210:88–90

    Google Scholar 

  • Piercey MF, Tian Y, Lum JT, Hoffmann WE, Collins RJ, Cooper MM, Lookingland K, Moore KE (1990) Region-specific tolerance to the 5-HT1A agonist ipsapirone. Soc Neurosci Abstr 16:1323

    Google Scholar 

  • Pinto W, Cabrera T, Li Q, Van de Kar L, Battaglia G (1994) Receptor reserve for 5-HT1A receptors in rat brain as assessed by neuroendocrine responses to 8-OH-DPAT. Soc Neurosci Abstr 20:1539

    Google Scholar 

  • Pranzatelli MR, Pluchino RS (1991) The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat. Pharmacol Biochem Behav 39:407–413

    Google Scholar 

  • Prehn JHM, Backhauß C, Karkoutly C, Nuglisch J, Peruche B, Roßberg C, Krieglstein J (1991) Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur J Pharmacol 203:213–222

    Google Scholar 

  • Przegalinski E, Tatarczynska E, Klodzinska A, Chojnacka-Wójcik (1994) The role of postsynaptic 5-HT1A receptors in the anti-conflict effect of ipsapirone. Neuropharmacology 33:1109–1115

    Google Scholar 

  • Rényi L, Jimenez P (1993) Modulation of central 5-HT1A and 5-HT2 receptor-mediated functional responses in rats following repeated treatment with 8-OH-DPAT. Behav Pharmacol 4:462–463

    Google Scholar 

  • Rényi L, Ängeby Möller K, Ensler K, Evenden J (1992) The non-competitive NMDA receptor antagonist (+)MK-801 counteracts the long-lasting attenuation of the hypothermic response induced by acute doses of 8-OH-DPAT. Neuropharmacology 31:1265–1268

    Google Scholar 

  • Romero L, Celada P, Artigas F (1994a) Inhibition of 5-HT release after the selective blockade of the 5-HT transporter: role of somatodendritic 5-HT1A autoreceptors. Neuropsychopharmacology 10:93S

    Google Scholar 

  • Romero L, Celada P, Artigas F (1994b) Reduction of in vivo striatal 5-HT release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus. Eur J Pharmacol 265:103–106

    Google Scholar 

  • Rowan MJ, Anwyl R (1987) Neurophysiological effects of buspirone and ipsapirone in the hippocampus: comparison with 5-hydroxytryptamine. Eur J Pharmacol 132:93–96

    Google Scholar 

  • Schechter LE, Bolaños FJ, Gozlan H, Lanfumey L, Haj-Dahmane S, Laporte A-M, Fattaccini C-M, Hamon M (1990) Alterations in central serotonergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. J Pharmacol Exp Ther 255:1335–1347

    Google Scholar 

  • Schmidt BH, Chaouloff F (1993) Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects. Psychoneuroendocrinology 18:457–466

    Google Scholar 

  • Schreiber R, De Vry J (1993a) 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action? Prog Neuropsychopharmacol Biol Psychiatry 17:87–104

    Google Scholar 

  • Schreiber R, De Vry J (1993b) Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat. Eur J Pharmacol 249:341–351

    Google Scholar 

  • Schreiber R, De Vry J (1993c) Neuroanatomical basis for the antidepressant-like effects of the 5-HT1A receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol 4:625–636

    Google Scholar 

  • Schreiber R, De Vry J (1993d) Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat. J Pharmacol Exp Ther 265:572–579

    Google Scholar 

  • Schreiber R, Opitz K, Glaser T, De Vry J (1993) Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors. Psychopharmacology 112:100–110

    Google Scholar 

  • Sharp T, McQuade R, Bramwell S, Hjorth S (1993) Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 348:339–346

    Google Scholar 

  • Sommermeyer H, Schreiber R, Greuel JM, De Vry J, Glaser T (1993) Anxiolytic effects of the 5-HT1A receptor agonist ipsapirone in the rat: neurobiological correlates. Eur J Pharmacol 240:29–37

    Google Scholar 

  • Sprouse JS, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27:707–715

    Google Scholar 

  • Stahl SM, Gastpar M, Keppel Hesselink JM, Traber J (1992) Serotonin1A receptors in depression and anxiety. Raven Press, New York

    Google Scholar 

  • Stefanski R, Palejko W, Bidzinski A, Kostowski W, Plaznik A (1993) Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists. Neuropharmacology 32:977–985

    Google Scholar 

  • Svensson L, Engel J, Hård E (1989) Effects of the 5-HT receptor agonist, 8-OH-DPAT, on ethanol preference in the rat. Alcohol 6:17–21

    Google Scholar 

  • Svensson L, Fahlke C, Hård E, Engel JA (1993) Involvement of the serotonergic system in ethanol intake in the rat. Alcohol 10:219–224

    Google Scholar 

  • Tanda G, Carboni E, Frau R, di Chiara G (1994) Increase of extra-cellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential. Psychopharmacology 115:285–288

    Google Scholar 

  • Tomkins DM, Higgins GA, Sellers EM (1993) Enhancement of ethanol intake in Wistar rats following pretreatment with low doses of 8-OH DPAT and gepirone using a limited access paradigm. Br J Pharmacol 108:93P

    Google Scholar 

  • Tomkins DM, Higgins GA, Sellers EM (1994a) Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake. Psychopharmacology 115:173–179

    Google Scholar 

  • Tomkins DM, Sellers EM, Fletcher PJ (1994b) Median and dorsal raphe injections of the 5-HT1A agonist, 8-OH-DPAT, and the GABAA agonist, muscimol, increase voluntary ethanol intake in Wistar rats. Neuropharmacology 33:349–358

    Google Scholar 

  • Traber J, Glaser T (1987) 5-HT1A receptor-related anxiolytics. Trends Pharmacol Sci 8:432–437

    Google Scholar 

  • Varrault A, Leviel V, Bockaert J (1991) 5-HT1A-sensitive adenylyl cyclase of rodent hippocampal neurons: effects of antidepressant treatments and chronic stimulation with agonists. J Pharmacol Exp Ther 257:433–438

    Google Scholar 

  • Wadenberg ML, Ahlenius S (1991) Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy. J Neural Transm 83:43–53

    Google Scholar 

  • Welner SA, de Montigny C, Desroches J, Desjardins P, Suranyi-Cadotte BE (1989) Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse 4:347–352

    Google Scholar 

  • Wieland S, Fischette C, Lucki I (1993) Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors. Neuropharmacology 32:561–573

    Google Scholar 

  • Wilde CH, Vogel WH (1994) Influence of the 5-HT1A receptor agonist ipsapirone on voluntary alcohol intake in rats. Alcohol 11:411–415

    Google Scholar 

  • Wolff MC, Leander JD (1994) Antiemetic effects of 5-HT1A agonists in the pigeon. Pharmacol Biochem Behav 49:385–391

    Google Scholar 

  • Yocca FD, Iben L, Meller E (1992) Lack of apparent receptor reserve at postsynaptic 5-hydroxy-tryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Mol Pharmacol 41:1066–1072

    Google Scholar 

  • Yocca FD, Eison AS, Hyslop DK, Ryan E, Taylor DP, Gianutsos G (1991) Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment. Life Sci 49:1777–1785

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Troponwerke GmbH & Co. KG, Institute for Neurobiology, Berliner Strasse 156, D-51063, Cologne, Germany

    J. De Vry

Authors
  1. J. De Vry
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Vry, J. 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121, 1–26 (1995). https://doi.org/10.1007/BF02245588

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245588

Key words

Search

Navigation